glp-1 compounds Compound versions of drugs for weight loss halted by FDA What should you know before

First-time GLP-1 prescribing rates increased 13.3% from December 2025 to March 2026, according to Truveta Research

In a major step forward, the FDA approved the first generic liraglutide for weight loss in August 2025, making these treatments more affordable

Myth: Skin pain on Ozempic means I am having an allergic reaction. Fact: Skin tenderness without a rash is typically a nerve-related side effect called allodynia

Together, these actions help patients experience faster, more efficient weight loss

No need to mix or prepare

Many gastrointestinal effects are transient, but persistent or severe symptoms should not be ignored